(Q40394899)

20 September 2017

1 reference

title

Inhibition of tumor angiogenesis (English)

1 reference

20 September 2017

1 reference

3

Weingart JD

1 reference

20 September 2017

Sipos EP

1

1 reference

20 September 2017

Tamargo RJ

series ordinal

2

1 reference

20 September 2017

Brem H

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

Annals of the New York Academy of Sciences

20 September 2017

1 reference

20 September 2017

732

1 reference

20 September 2017

263-272

1 reference

Tumor angiogenesis: a possible control point in tumor growth

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Self-regulation of growth in three dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Tumor dormancy in vivo by prevention of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Avascular and vascular phases of tumour growth in the chick embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Inhibition of tumor angiogenesis mediated by cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Identification of an Inhibitor of Neovascularization from Cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Angiostatic steroids. Method of discovery and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Chemical modification of fumagillin. I. 6-O-acyl, 6-O-sulfonyl, 6-O-alkyl, and 6-O-(N-substituted-carbamoyl)fumagillols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Control of tumor growth in animals by infusion of an angiogenesis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Polymers for the sustained release of proteins and other macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

Protamine is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB24741.X

10.1111/J.1749-6632.1994.TB24741.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference